Get notified of page updates

Search Results: Prevention, Detection & Risk + Colorectal Cancer (7 results)

New Search
PRINTER FRIENDLY PAGE 1 through 7 of 7

Prevention
A study testing two multi-cancer detection blood tests in people who do not have cancer

Multi-Cancer Detection Blood Tests in Adults Without Cancer: Vanguard Study

The Vanguard Study is looking at how multi-cancer detection (MCD) blood tests could fit into cancer screening.

Clinicaltrials.gov identifier: NCT06995898

Prevention
Observational study of a blood test for finding possible cancers earlier in people who have a high risk of cancer

Study of a Blood Test to Look for Signs of Cancer in Higher-Risk People (CHARM2)

This study is looking at how well an experimental blood test works for finding possible cancers earlier in people who have a higher-than-average risk of cancer because of an inherited mutation.

Clinicaltrials.gov identifier: NCT06726642
VIRTUAL

Prevention
Study for people at risk of cancer, including previvors, survivors and family members

An Early Detection and Prevention Study for People with an Increased Risk of Cancer (InAdvance)

This study collects health information and DNA samples such as blood or saliva from participants to help researchers better understand cancer risk and early detection.

Clinicaltrials.gov identifier: NCT05463796

Prevention
Prevention study for people with Familial Adenomatous Polyposis (FAP) who have polyps in the colon or rectum

Using the Drug eRapa to Prevent the Growth of Polyps in People with Familial Adenomatous Polyposis (SERENTA)

The purpose of this study is to find out if a medication called eRapa can help slow down the formation of polyps in people with Familial Adenomatous Polyposis (FAP).

Clinicaltrials.gov identifier: NCT06950385

Prevention
Prevention study for people with an APC mutation and FAP who have had colectomy surgery

Testing the Safety And Action of the Investigational Drug REC-4881 in People With Familial Adenomatous Polyposis (FAP) (TUPELO Study)

This study is looking at how safe and effective the research drug REC-4881 is for treating polyps in people with Familial Adenomatous Polyposis (FAP). Participants will receive the oral drug REC-4881. A participant's dose will depend on when they join the study. 

Clinicaltrials.gov identifier: NCT05552755

Prevention
People with Lynch Syndrome at risk for colon cancer

Collecting Blood and Stool Samples to Detect Colorectal Cancer or Precancerous Polyps in Lynch Syndrome Patients (CORAL Study)

This study will colect blood and stool samples to detect colorectal cancer or precancerous polyps in people with Lynch syndrome and those diagnosed with early onset colorectal cancer, diagnosed younger than 50 years old. 

Clinicaltrials.gov identifier: NCT05410977

Prevention
Prevention study for people with Lynch syndrome

A Study Comparing Two Anti-inflammatory Medications Naproxen or Aspirin for Cancer Prevention in Lynch Syndrome

The trial is enrolling people with Lynch syndrome. On average, the length of this study will last one year from the start of enrollment to completion. The study will measure  the effect of naproxen or aspirin on the immune cells in the gastrointestinal tract of people with Lynch syndrome. The trial will also evaluate any symptoms from the medications and any other changes of the colon and rectum.

Clinicaltrials.gov identifier: NCT05411718
Additional Results on Clinicaltrials.gov Prevention, Detection & Risk + Colorectal Cancer
28 results
Clinical Trial Official Title
NCT05612347 Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
NCT06117241 Reducing Metabolic Dysregulation in Dyads
NCT06763432 Positive Fit to Colonoscopy: Closing the Gap
NCT05524428 Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study
NCT06864338 Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test
NCT06745895 Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening
NCT05732623 Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
NCT04792684 Collection of Samples USOPTIVAL Study
NCT06342440 Early Detection of Advanced Adenomas and Colorectal Cancer
NCT05447923 Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities
NCT06708429 Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
NCT06880055 Shield Post-Approval Study Protocol
NCT05410977 Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
NCT07046585 Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)
NCT07436078 Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
NCT07095517 Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors
NCT06542835 Community Partnership for Telehealth Solutions to Convey Information and Enhance Care
NCT06682650 Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
NCT07393906 Colorectal Cancer Prevention Research Study: Eat Right, Screen Right
NCT06059963 A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation
NCT06757192 CRC Screening in Unscreened Individuals 45-54
NCT05694559 Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics
NCT07229443 CoGENES Randomized Controlled Trial (RCT)
NCT06620627 Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection
NCT07086833 The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities
NCT06612281 Evaluation of Gixam's Performance in a FIT Negative Population
NCT05929820 Impact of Protect Your Colon™ on CRC Screening
NCT00843375 Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas

Sponsored By